What is it about?
Describes a study comparing a new skin surveillance strategy for people high risk of melanoma, to current routine care. The intensive surveillance program incorporates novel 3D total body imaging technology, holistic risk stratification for targeted screening, and evaluation of extending this technology through a telehealth network. This study will evaluate if this surveillance program can be cost effective and provide superior clinical outcomes over current routine clinical care.
Featured Image
Why is it important?
This will be the first RCT to compare novel 3D-full body photography technology to current standard-of-care for people who are at high risk of melanoma.
Read the Original
This page is a summary of: Evaluation of the efficacy of 3D total-body photography with sequential digital dermoscopy in a high-risk melanoma cohort: protocol for a randomised controlled trial, BMJ Open, November 2019, BMJ,
DOI: 10.1136/bmjopen-2019-032969.
You can read the full text:
Contributors
The following have contributed to this page
